GLP-1s (Glucagon-Like Peptide-1 receptor agonists) are a class of medications originally developed to help manage type 2 diabetes
In the results, we see that both the intervention groups lost weight
Exp Neurol 150:4044 Sofic E, Lange KW, Jellinger K, Riederer P (1992) Reduced and oxidized glutathione in the substantia nigra of patients with Parkinson's disease
Using the wrong protocol for your purpose means either underdosing or overdosing
He added, As with all obesity treatments, including medications and bariatric surgery, long-term success depends on integrating these interventions with healthy eating, regular physical activity, and ongoing behavioral support. Other reasons to stop semaglutide treatment include being unable to tolerate side effects, taking a contraindicated medication, or being unable to sustain long-term use financially